American Century Companies Inc. Takes Position in Grail, Inc. (NASDAQ:GRAL)

American Century Companies Inc. acquired a new stake in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 11,990 shares of the company's stock, valued at approximately $214,000.

Other institutional investors also recently bought and sold shares of the company. Douglas Lane & Associates LLC bought a new position in shares of Grail during the 4th quarter worth approximately $3,034,000. A. D. Beadell Investment Counsel Inc. purchased a new position in Grail in the fourth quarter worth $430,000. FNY Investment Advisers LLC acquired a new position in shares of Grail during the fourth quarter worth $26,000. 180 Wealth Advisors LLC purchased a new stake in shares of Grail during the 4th quarter valued at $1,681,000. Finally, B & T Capital Management DBA Alpha Capital Management acquired a new stake in shares of Grail in the 4th quarter worth $387,000.

Analyst Ratings Changes

Separately, Morgan Stanley upped their target price on Grail from $16.00 to $20.00 and gave the company an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Stock Up 1.9 %

GRAL stock traded up $0.50 during trading on Friday, reaching $27.00. The company had a trading volume of 642,745 shares, compared to its average volume of 1,221,381. Grail, Inc. has a twelve month low of $12.33 and a twelve month high of $63.99. The firm has a 50-day simple moving average of $32.83 and a 200-day simple moving average of $23.64.

Grail (NASDAQ:GRAL - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share for the quarter, beating analysts' consensus estimates of ($4.41) by $2.55. The company had revenue of $38.25 million for the quarter, compared to analysts' expectations of $35.33 million. Sell-side analysts forecast that Grail, Inc. will post -15.15 earnings per share for the current year.

Insider Activity

In other news, President Joshua J. Ofman sold 2,109 shares of the stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total value of $65,800.80. Following the sale, the president now owns 559,673 shares in the company, valued at $17,461,797.60. This represents a 0.38 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Robert P. Ragusa sold 7,625 shares of the business's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the transaction, the chief executive officer now owns 828,662 shares of the company's stock, valued at $25,862,541.02. This represents a 0.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 11,550 shares of company stock valued at $360,436.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.